Childhood Hematologic Malignancy Center Treatment Team

Short placeholder heading

Our internationally recognized pediatric hematologists/oncologists and hematopathologists are world leaders in diagnosing and treating all types of pediatric blood cancers. In addition to treating lymphomas and leukemias, our pediatric hematologists/oncologists also treat histiocytosis, which is not a form of cancer but shares some of the characteristics of cancer and is often treated by pediatric hematologist/oncologists using some of the same therapies.

Center and Program Leadership

Andrew E. Place, MD, PhD
Vice President, Chief Medical Officer

Kimberly Stegmaier, MD
Co-Director of the Hematologic Malignancy Center (Basic & Translational Research)

Jessica A. Pollard, MD
Acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), myeloid malignancies, myeloproliferative disorders (CML, JMML, Down’s syndrome-associated Transient Myeloproliferative Disease, and other rare myeloid disorders)

Melissa Burns, MD
Early phase trials in high risk leukemia

Kimberly J. Davies, MD
Non-Hodgkin's lymphoma

Barbara A. Degar, MD
Langerhans cell histiocytosis (LCH), hemophagocytic lymphohistiocytosis (HLH)

Angela M. Feraco, MD, MMSc
Hodgkin lymphoma

Jennifer C. Kesselheim, MD, M.Ed
All types of leukemia and lymphoma, medical education

Lynda M. Vrooman, MD
Cancer survivorship and late effects of cancer treatment